Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kodiak Sciences Inc

Clinical trials sponsored by Kodiak Sciences Inc, explained in plain language.

Kodiak Sciences KOD NASDAQ

Ophthalmology biotech focused on retinal disease treatments.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New eye drug could save sight for millions with diabetes

Disease control Completed

This study tested an eye injection called tarcocimab in 255 people with diabetic retinopathy, a diabetes complication that can damage vision. Participants received either the drug or a sham (fake) injection. The goal was to see if the drug improves the severity of the disease and…

Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC